SpringWorks Therapeutics Inc (SWTX)
42.81
-1.46
(-3.30%)
USD |
NASDAQ |
May 23, 16:00
42.82
0.00 (0.00%)
After-Hours: 20:00
SpringWorks Therapeutics Free Cash Flow: -244.89M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -244.89M |
| December 31, 2023 | -230.18M |
| September 30, 2023 | -225.73M |
| June 30, 2023 | -194.78M |
| March 31, 2023 | -185.48M |
| December 31, 2022 | -171.76M |
| September 30, 2022 | -163.62M |
| June 30, 2022 | -167.76M |
| March 31, 2022 | -159.82M |
| Date | Value |
|---|---|
| December 31, 2021 | -129.89M |
| September 30, 2021 | -67.06M |
| June 30, 2021 | -54.66M |
| March 31, 2021 | -37.42M |
| December 31, 2020 | -32.83M |
| September 30, 2020 | -63.95M |
| June 30, 2020 | -60.28M |
| March 31, 2020 | -57.23M |
| December 31, 2019 | -48.11M |
Free Cash Flow Range, Past 5 Years
-244.89M
Minimum
Mar 2024
-32.83M
Maximum
Dec 2020
-127.53M
Average
-144.86M
Median
Free Cash Flow Benchmarks
| Geron Corp | -184.70M |
| Verastem Inc | -94.50M |
| Karyopharm Therapeutics Inc | -117.73M |
| Syndax Pharmaceuticals Inc | -204.92M |
| Arvinas Inc | -356.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -78.93M |
| Cash from Investing (Quarterly) | 21.46M |
| Cash from Financing (Quarterly) | -0.552M |
| Free Cash Flow Per Share (Quarterly) | -1.078 |
| Free Cash Flow to Equity (Quarterly) | -79.51M |
| Free Cash Flow Yield | -8.66% |